Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-24

Clinical Trial Update: Cutaneous Lupus Medication Experience Study

View source ↗

Summary

The Wake Forest University Health Sciences-sponsored clinical trial evaluating a medication experience in cutaneous lupus has completed (NCT02176148).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Cutaneous Lupus | Status: COMPLETED